Your browser doesn't support javascript.
loading
Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General's My Family Health Portrait.
Feero, W Gregory; Facio, Flavia M; Glogowski, Emily A; Hampel, Heather L; Stopfer, Jill E; Eidem, Haley; Pizzino, Amy M; Barton, David K; Biesecker, Leslie G.
Afiliação
  • Feero WG; Maine-Dartmouth Family Medicine Residency, Fairfield, Maine, USA.
  • Facio FM; Inova Translational Medicine Institute, Falls Church, Virginia, USA.
  • Glogowski EA; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Hampel HL; Division of Human Genetics, The Ohio State University, Columbus, Ohio, USA.
  • Stopfer JE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Eidem H; Department of Genetics, Vanderbilt University, Nashville, Tennessee, USA.
  • Pizzino AM; White Matter Disease Program, Children's National Health System, Washington, DC, USA.
  • Barton DK; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
  • Biesecker LG; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Genet Med ; 17(9): 753-6, 2015 Sep.
Article em En | MEDLINE | ID: mdl-25521335
ABSTRACT

PURPOSE:

This study examines the analytic validity of a software tool designed to provide individuals with risk assessments for colorectal cancer based on personal health and family history information. The software is compatible with the US Surgeon General's My Family Health Portrait (MFHP).

METHODS:

An algorithm for risk assessment was created using accepted colorectal risk assessment guidelines and programmed into a software tool (MFHP). Risk assessments derived from 150 pedigrees using the MFHP tool were compared with "gold standard" risk assessments developed by three expert cancer genetic counselors.

RESULTS:

Genetic counselor risk assessments showed substantial, but not perfect, agreement. MFHP risk assessments for colorectal cancer yielded a sensitivity for colorectal cancer risk of 81% (95% confidence interval 54-96%) and specificity of 90% (95% confidence interval 83-94%), as compared with genetic counselor pedigree review. The positive predictive value for risk for MFHP was 48% (95% confidence interval 29-68%), whereas the negative predictive value was 98% (95% confidence interval 93-99%). Agreement between MFHP and genetic counselor pedigree review was moderate (κ = 0.54).

CONCLUSION:

The analytic validity of the MFHP colorectal cancer risk assessment software is similar to those of other types of screening tools used in primary care. Future investigations should explore the clinical validity and utility of the software in diverse population groups.Genet Med 17 9, 753-756.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medição de Risco / Anamnese Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Genet Med Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medição de Risco / Anamnese Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Genet Med Ano de publicação: 2015 Tipo de documento: Article